Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Treatment Reviews|November 21, 2022
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic reviewCaterina Vaghi, Gianluca Mauri, Alberto Giuseppe Agostara, et al.
International Journal of Molecular Sciences|March 28, 2024
Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the QuiverJavier Ros, Caterina Vaghi, Iosune Baraibar, et al.
Targeted Oncology|March 19, 2021
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNAGiorgio Patelli, Caterina Vaghi, Federica Tosi, et al.
Expert Opinion on Investigational Drugs|May 22, 2024
Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapyNadia Saoudi González, Paola Valeria Marchese, Iosune Baraibar, et al.
Genes|May 4, 2026
Genomic Landscape, Targeted Therapies, and Mechanisms of Resistance in Molecularly Selected Metastatic Colorectal Cancer PatientsPatricia Garcia Pastor, Nadia Saoudi González, Francesc Salva, et al.
Cancer Treatment Reviews|January 14, 2026
Exploring resistance to immune checkpoints inhibitors in mismatch repair-deficient or microsatellite-instable colorectal cancerClara Salva de Torres, Evelyn Elias, Caterina Vaghi, et al.
Drugs|November 17, 2025
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging StrategiesCaterina Vaghi, Federica Tosi, Gianluca Mauri, et al.
The Oncologist|April 7, 2019
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Alessio Amatu, Luca Porcu, et al.
Pageof 1